𝔖 Bobbio Scriptorium
✦   LIBER   ✦

114. Long term survival following a randomized controlled trial of cetuximab plus chemotherapy for patients with KRAS wild-type unresectable colorectal liver-limited metastases

✍ Scribed by Xu, J.; Ye, L.C.; Liu, T.S.; Ren, L.; Wei, Y.; Zhu, D.X.; Zai, S.Y.; Ye, Q.H.; Yu, Y.; Xu, B.; Qin, X.Y.


Book ID
126701446
Publisher
Elsevier Science
Year
2014
Tongue
English
Weight
42 KB
Volume
40
Category
Article
ISSN
0748-7983

No coin nor oath required. For personal study only.